Roberta Zappasodi Selected Research

Roberta Zappasodi Research Topics

Disease

42	Neoplasms (Cancer) 03/2024 - 01/2009
6	Melanoma (Melanoma, Malignant) 01/2024 - 05/2014
6	Lymphoma (Lymphomas) 01/2021 - 11/2010
3	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2015
1	Triple Negative Breast Neoplasms 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Nasopharyngeal Carcinoma 01/2020
1	Genomic Instability 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017
1	Communicable Diseases (Infectious Diseases) 11/2017
1	Carcinoma (Carcinomatosis) 09/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2016
1	Breast Neoplasms (Breast Cancer) 11/2014
1	Carcinogenesis 11/2014
1	Experimental Melanoma 05/2014
1	Necrosis 10/2011

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2015
5	VaccinesIBA 01/2024 - 05/2014
4	pembrolizumabIBA 01/2022 - 04/2015
4	AntibodiesIBA 01/2019 - 11/2010
4	AntigensIBA 11/2017 - 05/2014
3	Peptides (Polypeptides)IBA 01/2022 - 01/2009
2	ChromatinIBA 03/2024 - 01/2021
2	eprenetapoptIBA 01/2024 - 01/2022
2	NivolumabIBA 01/2022 - 09/2016
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2020
2	CalreticulinIBA 01/2022 - 11/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2015 - 11/2010
1	Immunomodulating AgentsIBA 01/2024
1	Cancer VaccinesIBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Gemcitabine FDA Link 01/2022
1	IpilimumabIBA 01/2022
1	PhosphatidylserinesIBA 12/2021
1	ParaffinIBA 01/2021
1	LipidsIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	CCR8 ReceptorsIBA 01/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2021
1	EnzymesIBA 11/2020
1	Tryptophan (L-Tryptophan)FDA Link 11/2020
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 11/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2020
1	Lactate Dehydrogenase 5IBA 01/2020
1	Silybin (Lagosa)IBA 01/2020
1	ChemokinesIBA 01/2019
1	CytokinesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	EpitopesIBA 11/2017
1	Monoclonal AntibodiesIBA 09/2016
1	Brentuximab VedotinIBA 09/2016
1	atezolizumabIBA 09/2016
1	Oncogene Proteins (Oncogene Protein)IBA 03/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2015
1	Eukaryotic Initiation Factor-4EIBA 11/2014
1	Trastuzumab (Herceptin)FDA Link 11/2014
1	givinostat hydrochlorideIBA 11/2014
1	Protein Isoforms (Isoforms)IBA 11/2014
1	MicroRNAs (MicroRNA)IBA 11/2014
1	proto-oncogene proteins pimIBA 11/2014
1	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 11/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2014
1	Histone Deacetylase InhibitorsIBA 11/2014
1	Therapeutic UsesIBA 05/2014
1	AutoantigensIBA 05/2014
1	dopachrome isomeraseIBA 05/2014
1	ProteomeIBA 10/2011
1	Granzymes (Granzyme)IBA 10/2011
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 11/2010
1	HLA-A*02:01 antigenIBA 01/2009
1	Interleukin-4 (Interleukin 4)IBA 01/2009
1	Biotin (Vitamin H)FDA Link 01/2009

Therapy/Procedure

21	Immunotherapy 03/2024 - 01/2015
9	Therapeutics 11/2023 - 11/2014
2	Aftercare (After-Treatment) 01/2023 - 01/2020
1	Radiotherapy 12/2021
1	Precision Medicine 01/2021